Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 2121-2140 of 3,895 trials

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

NCT02390245

The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect, treat, and manage high-risk patients with previously undiagnosed glaucoma and other eye diseases. Research shows that subject failure to attend follow-up eye care appointments diminishes any previous benefits of community screenings for glaucoma. Greater adherence to follow-up visits can reduce glaucomatous blindness.

GlaucomaGlaucoma SuspectDiabetic Retinopathy+10 more

Wills Eye906 participantsStarted Sep 2014

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

NCT02552212

Patients with active Axial Spondyloarthritis without x-ray evidence of Ankylosing Spondylitis and with signs of inflammation will be randomly assigned to receive certolizumab pegol (CZP) 200 mg every two weeks or placebo. The primary objective is to demonstrate the efficacy of CZP in these patients.

Axial SpondyloarthritisNonradiographic Axial SpondyloarthritisNr-axSpA

UCB BIOSCIENCES GmbH317 participantsStarted Sep 2015

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +102 more locations

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

Rheumatoid Arthritis Trials in Other Cities

Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome

A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Other Conditions in Philadelphia